This review highlights skin cancer prevalence, treatment options, and market growth trends, indicating the importance of early detection and effective therapies.
Skin cancer is one of the most common cancer types, affecting approximately 20 percent of Americans throughout their lifetime. There are a multitude of types but the majority of skin cancer cases are one of three types: Melanoma, Basal cell carcinoma, and Squamous cell carcinoma. Like most cancers, early detection for skin cancer and access to proper treatments are keys to increasing survival rates. Constant interest in increasing survival rates have led to the combined skin cancer diagnostics and treatment market to have grown to 19.83 billion USD market size as of 2023. The diagnostics are visually based and encompass both a doctor assessment and an additional biopsy for closer identification. The variety of treatments are more extensive than the common diagnostic techniques and include drugs, radiation, and surgery. This review aims to increase understanding of the three major skin cancer types better, including the physiology of the healthy skin, the causes, risks, and detection of skin cancer, the physiology of each different cancer type, the market size, segments, and trends of skin cancer, the current available treatments - both commonplace and tissue engineered, the possible treatment options in clinical trials and being researched.
No takes yet. Share an insight, caveat, or question.
Welsh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: